Evaxion to host R&D Day on May 25, 2023
COPENHAGEN, Denmark, May 16, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the discovery and development of AI-powered immunotherapies, today announced that it will hold an R&D Day at 12:30 p.m CEST on May 25, 2023.
The R&D Day will feature a series of talks from Evaxion scientists and collaborators, sharing previously unreleased preclinical data highlighting the use of Evaxion’s proprietary genetic immune adjuvant (Antigen Presenting Cell targeting) technology. This technology has been shown to enhance vaccination effects for both DNA and mRNA vaccines across a range of therapeutic vaccine applications.
The event will be hosted with the possibility for physical attendance at Evaxion’s facilities in Hørsholm, Denmark and as a live webcast. Please visit https://investors.evaxion-biotech.com/events/event-details/rd-day for further information on the R&D Day, registration details, and to access a replay of the webcast after the event.
About Evaxion
Evaxion Biotech A/S is a pioneering company developing AI-powered immunotherapies. Evaxion’s proprietary and scalable AI technologies decode the human immune system to discover and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has a broad pipeline of candidates, including three personalized cancer immunotherapies. It is located in Hørsholm, Denmark, with 50 employees listed on the Nasdaq New York stock exchange. For more information, please visit www.evaxion-biotech.com.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
DFDS launches new Initiative to Protect Sperm Whales in Southern Greece1.6.2023 07:00:00 CEST | Press release
At DFDS, our awareness of how our ferry and logistics activities impact biodiversity is growing. We are taking essential steps to protect marine life in the Mediterranean around the Southern part of Greece, a critical habitat for endangered sperm whales. Sofie Lindegaard, Head of Group Sustainability, explains, "Our responsibility to the marine life in the waters we operate is crucial. We want to ensure that our operations respect the different ecosystems." "Working closely with NGOs is an invaluable way to get insights into important and sometimes unknown areas and constructive input on how to address it," Sofie adds. Together with a coalition of NGOs, including IFAW, Ocean Care, Pelagos Cetacean Institute, and WWF Greece, DFDS has developed initiatives to reduce vessel-whale collisions in the Hellenic Trench in Southern Greece: Route Adjustments: We have redefined our vessel routes to avoid high-risk areas known for frequent sperm whale sightings. Slow Steaming: We have limited vesse
DFDS omlægger ruter og sænker farten for at beskytte kaskelothvaler i det sydlige Grækenland1.6.2023 07:00:00 CEST | pressemeddelelse
I tæt samarbejde med en række NGO’er har DFDS taget væsentlige skridt for at beskytte havlivet i Middelhavet i Den Hellenske Grav i det sydlige Grækenland, et kritisk habitat for truede kaskelothvaler. Initiativerne skal mindske risikoen for kollisioner mellem skibe og hvaler. Ændringerne består af: Rutejusteringer: DFDS har justeret sine skibsruter for at undgå højrisikoområder kendt for hyppige observationer af kaskelothvaler.Lavere fart: DFDS har begrænset skibenes hastighed i disse højrisikozoner for at minimere potentialet for kollisioner.Øget overvågning og melding: DFDS har indført en politik, der opfordrer alle kaptajner til at være årvågne, identificere hvaler og hurtigt kommunikere observationer til DFDS' skibe og andre skibe i nærheden. "Vi er bevidste om at vores færgeaktiviteter kan have en påvirkning af biodiversiteten og føler et stort ansvar over for havlivet i de farvande, vi opererer i. Vi ønsker at sikre, at vores operationer respekterer de forskellige økosystemer,"
Aktias placeringsutsikt: Ränteplaceringar har gjort comeback, utsikterna för aktiemarknaden är osäkra1.6.2023 07:00:00 CEST | Pressemelding
Pressmeddelande Aktia Abp 1.6.2023 kl. 8.00 På placeringsmarknaden har år 2023 börjat i positiva tecken. I mitten av maj hade den globala aktiemarknaden avkastat cirka7 procent och räntemarknaden mellan0 och 4,5procent. Ränteplaceringar har gjort en snabb comeback och fungerar igen som ett skyddande element i portföljer med omfattande diversifiering. Aktia skriver i sin färska placeringsutsikt att det här året kommer att bli intressant för placeraren. De skador som kriget i Ukraina och inflationschocken orsakade utvecklingen förra året har korrigerats aktiemarknaden – utvecklingen har varit till och med överraskande positiv. Det i huvudsak positiva sentimentet har stött sig på den starka konsumentdrivna ekonomiska tillväxten och på att resultatutvecklingen har stått sig bättre än väntat. När det gäller aktier beräknas tillväxttakten avta eller till och med stanna upp helt under resten av året. För en allokeringsplacerare som utnyttjar olika tillgångsslag i sin placeringsverksamhet har
Vivoryon Therapeutics N.V. to Participate in Upcoming Conferences1.6.2023 07:00:00 CEST | Press release
Vivoryon Therapeutics N.V. to Participatein Upcoming Conferences Halle (Saale) / Munich, Germany, June1, 2023 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that the Company’s management will participate in the following conferences: BIO International Convention (June 5-8, 2023) Only one-on-one meetings Venue: Boston Convention & Exhibition Center; Boston, USA Jefferies Healthcare Conference (June7-9, 2023) Date: June 7, 2023 Presentation Time: 08:00 am EDT in Track 4 Venue: Marriott Marquis; New York City, USA A webcast of the presentation will be available via the "Presentations & Webcasts" page in the Investor Relations section on the Company's website at www.vivoryon.com and will be archived on the Company's website for 90 days following the conference. ### About Viv
Schweiter strengthens its Core Materials business – acquisition of JMB Wind Engineering completed1.6.2023 06:00:00 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR Schweiter strengthens its Core Materials business – acquisition of JMB Wind Engineering completed Schweiter Technologies is increasing its 40% minority holding by taking over the remaining 60% of the stock. The agreement to purchase the rest of the shares in JMB Wind Engineering (“JMB”) has been signed and completed, further strengthening the Core Materials business of 3A Composites. Steinhausen, 1 June 2023 – JMB (www.jmbwind.com) is a leading developer and producer of core material kits – primarily balsa and PET products for wind turbines. It is headquartered in Goleniów, Poland and has subsidiaries in Poland, Portugal and Brazil. The company acquired has approximately 430 employees and achieved sales of around EUR 70 million in the 2022 business year. Schweiter Technologies acquired a 40% share of JMB in 2021 to establish a strategic partnership with a leading European kitting company. The acquisition of the remaining holding in JMB and the